The Centre for Reproductive & Genetic Health (CRGH), Great Portland Street, London W1W 5QS, UK.
The Centre for Reproductive & Genetic Health (CRGH), Great Portland Street, London W1W 5QS, UK.
Eur J Obstet Gynecol Reprod Biol. 2024 Jul;298:35-40. doi: 10.1016/j.ejogrb.2024.04.033. Epub 2024 May 6.
To study the effect of double trophectoderm biopsy on clinical outcomes following single euploid blastocyst transfer.
Retrospective cohort study of 2046 single euploid frozen-thawed blastocyst transfers from January 2015 to June 2022 in a single centre. All patients undergoing a frozen-thawed embryo transfer (FTET) cycle with euploid blastocysts, biopsied for any indication, were included. The outcomes were compared for blastocysts which were biopsied and vitrified once (Group 1, n = 1684), biopsied once but vitrified twice (Group 2, n = 312) and biopsied and vitrified twice (Group 3n = 50). We adjusted for confounders and performed subgroup analysis for PGT-A, PGT-M and PGT-SR cycles. The primary outcome was live birth rate. Secondary outcomes included pregnancy, clinical pregnancy, birthweight and sex ratio.
After adjusting for confounders (previous failed euploid implantations, embryo quality and day of biopsy), embryos which were biopsied twice had lower OR for clinical pregnancy (0.48, CI 0.26-0.88, p = 0.019) and for live birth (0.50 CI 0.27-0.92, p = 0.025) compared to controls. Embryos which were biopsied once but vitrified twice had no different ORs for all reproductive outcomes compared to controls. No significant difference was observed for neonatal birthweight or sex ratio amongst the three groups. This is a retrospective single centre study with inherent bias and results may not be transferable to all settings.
This study is the largest to date assessing the outcomes of FTET cycles following double trophectoderm biopsy. The results are in keeping with the existing literature and can be incorporated into patient counselling. Whilst double biopsy seems to adversely impact LBR, it is only one of the many factors that can affect success rates. The subfertility background and embryo characteristics should not be overlooked. This study provides reassuring evidence since double biopsied embryos still result in live births with no difference in sex ratio or birthweight. However, long term follow up of the off-springs is lacking and should be reported in future studies.
研究双滋养层活检对单整倍体囊胚移植后临床结局的影响。
这是一项回顾性队列研究,纳入了 2015 年 1 月至 2022 年 6 月在单中心进行的 2046 例单整倍体冷冻解冻囊胚移植。所有接受整倍体囊胚冷冻解冻胚胎移植(FTET)周期且因任何原因活检的患者均纳入研究。比较了活检后仅进行一次玻璃化冷冻(第 1 组,n=1684)、活检后进行两次玻璃化冷冻(第 2 组,n=312)和活检后进行两次玻璃化冷冻(第 3 组,n=50)的囊胚的结局。我们调整了混杂因素,并对 PGT-A、PGT-M 和 PGT-SR 周期进行了亚组分析。主要结局是活产率。次要结局包括妊娠、临床妊娠、出生体重和性别比。
调整混杂因素(既往失败的整倍体着床、胚胎质量和活检日)后,与对照组相比,进行两次活检的胚胎临床妊娠的 OR(0.48,95%CI 0.26-0.88,p=0.019)和活产 OR(0.50,95%CI 0.27-0.92,p=0.025)均较低。仅进行一次活检但进行两次玻璃化冷冻的胚胎与对照组相比,所有生殖结局的 OR 无差异。三组新生儿出生体重或性别比无显著差异。这是一项回顾性单中心研究,存在固有偏倚,结果可能不适用于所有情况。
这项研究是目前评估双滋养层活检后 FTET 周期结局的最大研究。结果与现有文献一致,可纳入患者咨询。虽然双活检似乎会对活产率产生不利影响,但它只是影响成功率的众多因素之一。不应忽视不孕背景和胚胎特征。这项研究提供了令人安心的证据,因为双活检胚胎仍可活产,且性别比或出生体重无差异。然而,目前缺乏对后代的长期随访,应在未来的研究中报告。